AIM Vaccine Shrinks Its IPO But Gives Chairman a Mega Paycheck
China’s second-largest maker of non-Covid vaccines has finally crossed the IPO finish line and will list its shares next Thursday Key Takeaways: AIM Vaccine is finally landing on the Hong…
Recent Articles
RELATED ARTICLES
- Health Guard plans dual listing to fund HPV vaccine fight
-
With healthier finances, Clover Bio shifts to flu and RSV vaccines
2197.HK
-
Fosun Pharma, CanSino take different paths as Covid lift fade
2196.HK 6185.HK
- China’s mRNA pioneer Stemirna faces post-Covid reinvention test
-
FAST NEWS: AIM Vaccine’s loss balloons
6660.HK
-
FAST NEWS: AIM Vaccine named to MSCI small cap index
6660.HK
-
FAST NEWS: CanSino’s revenue plunges as demand dries up for Covid vaccines
6185.HK 688185.SHG
Discover hidden China stock gems in our weekly newsletter